Login
$UMEW
$1.15 +$0.00 (0.0%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Jun 30, 2026
Q2 FY2026
As of Mar 31, 2026
Q1 FY2026
As of Dec 31, 2025
Q4 FY2025
As of Sep 30, 2025
Q4 FY2024
As of Sep 30, 2024
Q4 FY2023
As of Sep 30, 2023
Q4 FY2022
As of Sep 30, 2022
Q4 FY2020
As of Sep 30, 2020
Q4 FY2019
As of Sep 30, 2019
Q4 FY2018
As of Sep 30, 2018
Q4 FY2017
As of Sep 30, 2017
Q4 FY2016
As of Sep 30, 2016
Q4 FY2015
As of Sep 30, 2015
Q1 FY2013
As of Dec 31, 2012
Q4 FY2012
As of Sep 30, 2012
Q3 FY2012
As of Jun 30, 2012
Q2 FY2012
As of Mar 31, 2012
Q1 FY2012
As of Dec 31, 2011
Q4 FY2011
As of Sep 30, 2011
Q3 FY2011
As of Jun 30, 2011
CURRENT ASSETS
Cash
Deposit
Cash
Deposit
Prepayment
Accounts Receivable
Inventory
TOTAL CURRENT ASSETS
Property and equipment, net
TOTAL NON-CURRENT ASSETS
TOTAL ASSETS
CURRENT LIABILITIES
Accounts Payable and Accrued Liabilities (Note 6)
Accounts payable
Due to related parties
Accrued liabilities and other payables
TOTAL CURRENT LIABILITIES
TOTAL LIABILITIES
Commitments and Contingencies
STOCKHOLDERS' DEFICIT
Ordinary shares: $ 0.0001 par value; Authorized: 250,000,000 shares; Issued and outstanding: 114,785,005 shares as of September 30, 2025 and 116,099,593 shares as of June 30, 2026
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders' deficit
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support